CNTB
Connect Biopharma Holdings
CNTB
CNTB
41 hedge funds and large institutions have $32.4M invested in Connect Biopharma Holdings in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
7.66% more ownership
Funds ownership: 15.14% → 22.8% (+7.7%)
Holders
41
Holding in Top 10
–
Calls
$526K
Puts
$230K
Top Buyers
| 1 | +$2.35M | |
| 2 | +$1.94M | |
| 3 | +$1.56M | |
| 4 |
Millennium Management
New York
|
+$1.11M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$808K |
Top Sellers
| 1 | -$228K | |
| 2 | -$163K | |
| 3 | -$111K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$61K |
| 5 |
Renaissance Technologies
New York
|
-$58.4K |
